secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2024-05-10T23:59:59+00:00
Accession:  0001493152-24-018687
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio appoints Margery Fischbein to Board of Directors
-------------------------------------------------------------

- Margery Fischbein appointed to the Board effective May 7, 2024; increases Board to 4 directors.
- Determined independent per SEC and Nasdaq rules; appointed to Audit Committee.
- Received option to purchase 1,000 shares at $7.90, vesting quarterly over 3 years.
- Fischbein is Managing Director at Cassel Salpeter & Co.; previously headed healthcare investment banking at Seaport Global and FBR.
- Press release issued May 7, 2024 announcing the appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315224018687/0001493152-24-018687-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315224018687/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-018687

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer